Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

Market Cap

13.56 Million USD

Sector

Financial Services

Description

China Botanic Pharmaceutical Inc.

Read More

Overview

Value

1

Growth

20

Health

21

Management

35

Analyst Opinion

0

Total

19

All Scores Out Of 100

Best Features

  • Has a low level of debt
  • Low preportion of income is paid as dividend
  • 0

Risk Factors

  • Overvalued on cashflow basis
  • Earnings have declined recently
  • Income is not covering expenditure and investment
  • Earnings are negative
  • Does not hold enough liquid assets to cover short term liabilities
  • Poor overall financial health
  • No margin of safety at their current market price
  • Poor earnings and cashflow growth

Market Peers

CBPI

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-102.80%

Revenue Growth (5 Year Average)

N/A

Ratings Consensus

N/A

Share Buybacks

N/A

Dividend Yeild (TTM)

N/A

Valuation

Value Score

1

  • Estimated intrinsic-value of NaN undefined USD is lower than current price ( 68.00 undefined USD)
  • Free-cashflow-yeild of -0.76% is worse than the market average (4.7%)
  • Margin-of-safety of -102.80% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/A

Current Price: 0.1 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-0.76%

PE/Earnings Growth

N/A

Price/Book

-166.12x

Growth

Growth Score

20

  • Revenue growth has improved this yeara
  • 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
  • 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
  • Earnings growth has slowed this year
  • 5 Year Average Free Cashflow growth of N/A is lower than the market average (12.35%)
  • Free Cashflow growth has slowed this year

Revenue Growth

N/A

Earnings Growth

N/A

Cashflow Growth

N/A

Health

Health Score

21

  • Has a low level of debt
  • Low financial Leverage
  • Normal operation does not require debt to be sustainable
  • Cashflow is negative
  • 0
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

N/A

Debt/Equity

N/Ax

Current Assets/Liabilities

N/Ax

Free Cashflow/Total Debt

N/Ax

Debt/Capital

N/Ax

Management

Management Score

35

  • Has not bought shares or issued new shares in the last 5 years
  • Return-on-equity of 6340.77% is higher than the market average (15%)
  • Return-on-capital-employed of -1034.06% is lower than the market average (10%)

Average Buybacks/Dilution

N/A

Recent Buybacks/Dilution

N/A

5 Year Price Volitility

176.94%

Return On Assets

N/A

Return On Capital Employed

-1034.06%

Return On Equity

6340.77%

Return On Free Cashflow

N/A

Return On Investments

N/A

Analysts

Analyst Opinion

0

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    Other Information

    Company Name

    China Botanic Pharmaceutical Inc.

    Currency

    USD

    Beta

    41.755215

    Vol Avg

    0

    Ceo

    Cik

    0000926844

    Cusip

    16890Y104

    Exchange

    Other OTC

    Full Time Employees

    Industry

    Shell Companies

    Sector

    Financial Services

    Ipo Date

    2000-03-27

    Address

    1185 Avenue of the Americas

    City

    New York

    State

    NY

    Country

    US

    Zip

    10004

    Phone

    646 768 8417

    All financial data provided by FMP

    Noticed an error with something on our site?

    We Use Cookies